Halogen Software is after topline growth, says Cantor’s Kew

Halogen Software CEO Paul Loucks. Cantor Fitzgerald analyst Justin Kew believes that Halogen Software’s business can support long-term EBITDA margins of more than 30%, but that the company will focus on revenue growth in the short term.

Halogen Software (Halogen Software Stock Quote, Chart, News: TSX:HGN) will continue to grow its topline aggressively for a couple years, and will only shift its focus to the bottom line when revenue growth slows, says Cantor Fitzgerald analyst Justin Kew.

Yesterday, after market, recent-IPO Halogen reported its Q2, 2013 results. The company lost (U.S.) $2.73-million on revenue of $10.1-million, up 26% from the same period a year prior.

CEO Paul Loucks said the quarter was about growth.

“We’re pleased with our strong progress in the second quarter,” he said. “We continued to deliver high growth rates in our recurring revenue thanks to a combination of attracting new customers and generating more revenue from our existing customers, who continued to renew with us at a rate greater than 90 per cent, reflecting the quality of our offering and our world-class customer experience.”

Kew says he expects Halogen will continue its land grab for some time, and will grow revenue aggressively to about $71-million by fiscal 2015. He thinks EBITDA margins will creep up during that time, but won’t be a focus of management until revenue growth slows. The Cantor Fitzgerald analyst believes that Halogen’s business can support long-term EBITDA margins of more than 30%. At $70-million in revenue, he notes, the company will support EBITDA of more than $21-million.

In a research update to clients this morning, Kew maintained his BUY rating and $18.25 one-year target on Halogen, implying a 22% return.

More Cantech Analysts

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: hgn
Nick Waddell

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.

Recent Posts

WELL Health inks five-year deal with Microsoft

It's become one of the biggest players in the Canadian healthcare space, now WELL Health (WELL Health Stock Quote, Chart,… [Read More]

20 hours ago

Is Thomson Reuters stock a buy right now?

Its stock has made a since last October, but is there more upside left in Thomson Reuters (Thomson Reuters Stock… [Read More]

21 hours ago

Is GOOGL still a buy?

Following a widely applauded first quarter beat, Roth MKM analyst Rohit Kulkarni has maintained his "Buy" rating on Alphabet (Alphabet… [Read More]

2 days ago

NLH has 173% upside, Echelon says

Following an acquisition, Echelon Capital Markets analyst Stefan Quenneville has maintained his "Buy" rating on Nova Leap Health (Nova Leap… [Read More]

2 days ago

Shopify upgraded to “Buy” at Citi

The stock has been flat since November, but Citi analyst Tyler Radke thinks there is now money to be made… [Read More]

2 days ago

Sabio has 400% upside, Eight Capital says

Following the company's fourth quarter results, Eight Capital analyst Kiran Sritharan has maintained his "Buy" rating on Sabio Holdings (Sabio… [Read More]

5 days ago